共 348 条
[1]
Harvey JM(1999)Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J Clin Oncol 17 1474-1481
[2]
Clark GM(2009)Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel J Clin Oncol 27 4701-4708
[3]
Osborne CK(2016)Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V J Clin Oncol 34 927-935
[4]
Allred DC(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717
[5]
Millar EK(2010)Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 1684-1691
[6]
Graham PH(2008)Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2373-2378
[7]
O’Toole SA(2006)Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials J Clin Oncol 24 2028-2037
[8]
McNeil CM(2007)Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer Ann Oncol 18 1632-1640
[9]
Browne L(2011)Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up J Pathol 223 358-365
[10]
Morey AL(2015)Multigene prognostic tests in breast cancer: past, present, future Breast Cancer Res 17 11-5312